Evidence map›Paper›PMID 21415847›Full record

ReviewNature reviews. Neuroscience2011

From glutamate co-release to vesicular synergy: vesicular glutamate transporters.

Salah El Mestikawy, Asa Wallén-Mackenzie, Guillaume M Fortin, Laurent Descarries, Louis-Eric Trudeau

Erratum issued Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06518941 (An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa), which is not on this map. Cited by 216 papers.

0numbers the graph read from it
0cells of the map it votes in
216citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06518941 phase2not yet recruitingnot on this mapstarted 2027, after this paper: background citation

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

TypeinterventionalSponsorNew York State Psychiatric InstituteRan2027 to 2028Enrolled10ConditionsAnorexia NervosaArmsDonepezil
3 · Its place in the literature

Who cites it

216 citing papers in PubMed, 379 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. VGLUT2 in Parkinson's disease: an emerging therapeutic target.Expert opinion on therapeutic targets · 2026
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

156 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors at 3 institutions in 5 countries.

Salah El MestikawyInstitut National de Santé et de Recherche Médicale (INSERM), U952, Centre National de Recherche Scientifique (CNRS) UMR 7224, Université Pierre et Marie Curie, Paris 06, Pathophysiology of Central Nervous System Disorders, 9 quai Saint Bernard, 75005 Paris, France.
Asa Wallén-Mackenzie
Guillaume M Fortin
Laurent Descarries
Louis-Eric Trudeau
Université de Montréal · CAMarie Curie · GBUppsala University · SE

Funding

Canadian Institutes of Health Research NRF‑3,544
6 · The paper itself

Abstract

Recent data indicate that 'classical' neurotransmitters can also act as co-transmitters. This notion has been strengthened by the demonstration that three vesicular glutamate transporters (vesicular glutamate transporter 1 (VGLUT1), VGLUT2 and VGLUT3) are present in central monoamine, acetylcholine and GABA neurons, as well as in primarily glutamatergic neurons. Thus, intriguing questions are raised about the morphological and functional organization of neuronal systems endowed with such a dual signalling capacity. In addition to glutamate co-release, vesicular synergy - a process leading to enhanced packaging of the 'primary' transmitter - is increasingly recognized as a major property of the glutamatergic co-phenotype. The behavioural relevance of this co-phenotype is presently the focus of considerable interest.

Indexed as

AnimalsBrainGlutamic AcidNeuronsNeurotransmitter AgentsVesicular Glutamate Transport ProteinsGlutamic AcidNeurotransmitter AgentsVesicular Glutamate Transport Proteins

Identifiers

PMID21415847
OpenAlexW1997896450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.